VHAM
GWPH

Van Hulzen Asset Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Van Hulzen Asset Management’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-5,240
Closed -$1.14M – 293
2021
Q1 		$1.14M Sell
5,240
-250
-5% -$47K 0.18% 82
2020
Q4 		$634K Sell
5,490
-450
-8% -$50.4K 0.1% 120
2020
Q3 		$578K Sell
5,940
-200
-3% -$23K 0.09% 118
2020
Q2 		$754K Sell
6,140
-560
-8% -$63.5K 0.11% 101
2020
Q1 		$587K Buy
6,700
+665
+11% +$70.4K 0.13% 104
2019
Q4 		$631K Buy
6,035
+150
+3% +$16.8K 0.12% 121
2019
Q3 		$677K Buy
5,885
+400
+7% +$60.7K 0.14% 106
2019
Q2 		$946K Sell
5,485
-150
-3% -$25.9K 0.21% 83
2019
Q1 		$950K Sell
5,635
-15
-0.3% -$2.23K 0.26% 77
2018
Q4 		$550K Buy
5,650
+1,470
+35% +$193K 0.16% 99
2018
Q3 		$722K Buy
4,180
+935
+29% +$135K 0.19% 94
2018
Q2 		$453K Buy
3,245
+735
+29% +$104K 0.13% 106
2018
Q1 		$283K Buy
2,510
+230
+10% +$28.9K 0.09% 152
2017
Q4 		$301K Buy
2,280
+260
+13% +$30.6K 0.09% 154
2017
Q3 		$205K Buy
+2,020
New +$216K 0.07% 167

Other funds holding GWPH

HDIM
Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

Van Hulzen Asset Management's GWPH Position: Q2 2021 in Review

Van Hulzen Asset Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 5,240 shares — an estimated $1.14M sold.

Van Hulzen Asset Management first reported a position in GWPH in Q3 2017 and held it in 15 quarters. The position peaked at $1.14M in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

  • Van Hulzen Asset Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
  • Van Hulzen Asset Management sold 5,240 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $1.14M.
  • Van Hulzen Asset Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q3 2017 and held it in 15 quarters.
  • Van Hulzen Asset Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $1.14M in Q1 2021.
  • 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Van Hulzen Asset Management's 13F filing for Q2 2021, filed 6 Aug 2021.